Adaptive Radiotherapy Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

What we are studying

The purpose of this study is to find out if more intense (higher dose) radiation treatment based on the FDG-PET/CT imaging improves treatment of your cancer with the same possible damage to healthy lung tissue compared to treatment with standard radiation therapy. The higher dose radiation is aimed at the tumor. The doses to normal tissues, such as heart, spinal cord, and esophagus are strictly limited and are kept at the same safe limits as in standard radiation.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with advanced non-small cell lung cancer (NSCLC)

What is involved

  • Chemotherapy and radiation treatment for 6 weeks
  • Additional 6 weeks of chemotherapy after completing radiation
  • Follow-Up visits: 1 month after the end of treatment; every 3 months for the first year; every 6 months for years 2 and 3; then once a year for life

Compensation

None

Contact Information

Study Coordinator
Rebecca Bishop
Email
rbishop@wakehealth.edu
Phone
336-713-6518

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.